首頁 > 市場調查報告書 > 製藥

消化器

耶爾森氏菌診斷市場規模、佔有率和成長分析（按產品、診斷測試、技術、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1899689

耶爾森氏菌診斷市場規模、佔有率和成長分析（按產品、診斷測試、技術、最終用戶和地區分類）—2026-2033年產業預測

Yersinia Diagnostics Market Size, Share, and Growth Analysis, By Product (Instruments, Kits and Reagents), By Diagnostic Test (Stool Culture, Imaging Tests), By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球耶爾森氏菌診斷市場規模預計在 2024 年達到 36.2 億美元，從 2025 年的 37.7 億美元成長到 2033 年的 52.4 億美元，在預測期（2026-2033 年）內複合年成長率為 4.2%。

全球耶爾森氏菌病診斷市場的主要驅動力是耶爾森氏菌感染疾病感染率的上升、診斷技術的進步以及人們對早期檢測和治療意識的提高。技術創新，尤其是分子診斷領域的創新，是推動市場成長的關鍵因素，同時加強食源性疾病的公共衛生教育也扮演了重要角色。耶爾森氏菌病病例數的增加也促進了市場擴張。然而，市場成長的潛在阻礙因素包括生產者之間日益激烈的競爭、政府醫療保健資金的限制以及機構的批量採購。該市場涵蓋多個地區，其中北美、歐洲和亞太地區是主要貢獻者，成熟企業和新興企業均提供各種診斷產品和服務。政府對醫療保健基礎設施的舉措和投資預計將推動未來的成長。

推動全球耶爾森氏菌診斷市場發展的因素

全球耶爾森菌診斷市場的主要促進因素之一是耶爾森菌感染疾病的日益流行，尤其是鼠疫耶爾森菌（鼠疫的病原體）和腸炎耶爾森菌（腸胃炎的主要病原體）。感染率的上升（通常與環境因素、旅行和都市化有關）推動了對準確快速診斷檢測的需求。此外，人們對通用感染疾病的認知不斷提高，以及早期檢測在控制感染傳播方面的重要性，正在推動對先進診斷工具研發的投資，最終促進市場成長並加強公共衛生應對機制。

全球耶爾森氏菌診斷市場限制因素

全球耶爾森氏菌診斷市場的主要限制因素之一是醫護人員和大眾對耶爾森氏感染疾病的認知和了解有限。這種知識差距會導致誤診和延誤診斷，從而阻礙對精準診斷工具的需求。此外，許多地區耶爾森氏菌感染疾病的盛行率相對較低，導致缺乏資金和研發舉措來開發先進的診斷解決方案，進一步阻礙了市場成長。因此，大眾對耶爾森氏菌相關健康問題的認知不足和重視程度不夠，為這個專業細分市場的製造商和相關人員帶來了挑戰。

全球耶爾森氏菌診斷市場趨勢

全球耶爾森氏菌診斷市場正經歷著向分子診斷技術的顯著轉變。其特點是聚合酵素鏈鎖反應(PCR) 檢測和核酸增幅檢查(NAAT) 等創新技術的日益普及，這些技術能夠有效檢測耶爾森氏菌。與傳統的培養方法相比，這些先進的分子方法因其更高的靈敏度和特異性以及更快的檢測速度而備受青睞。直接從臨床檢體中識別耶爾森氏菌 DNA 的能力實現了快速且準確的診斷，促使醫療機構和實驗室加強對分子診斷平台和檢測方法的投資。這推動了該細分市場的強勁成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Thermo Fisher Scientific（USA）
Bio-Rad Laboratories（USA）
Hologic, Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
Danaher Corporation（USA）
PerkinElmer, Inc.（USA）
QIAGEN NV（Netherlands）
F. Hoffmann-La Roche Ltd（Switzerland）
Siemens Healthineers AG（Germany）
bioMerieux SA（France）
Merck KGaA（Germany）
Lonza Group AG（Switzerland）
Agilent Technologies, Inc.（USA）
Illumina, Inc.（USA）
bioAffinity Technologies, Inc.（USA）
Gen-Probe Incorporated（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2897

Global Yersinia Diagnostics Market size was valued at USD 3.62 Billion in 2024 and is poised to grow from USD 3.77 Billion in 2025 to USD 5.24 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Yersinia diagnostics market is primarily fueled by the rising incidence of Yersinia infections, advancements in diagnostic technology, and heightened awareness surrounding early detection and treatment. Technological innovations, particularly in molecular diagnostics, are key growth catalysts, alongside increased public health education on food-borne diseases. The escalating number of yersiniosis cases also contributes to market expansion. However, market growth faces potential restraints from heightened competition among producers, limited government healthcare funding, and bulk purchasing by organizations. The market spans across multiple regions, with North America, Europe, and Asia Pacific as significant contributors, featuring both established and emerging companies delivering diverse diagnostic products and services. Government initiatives and investments in healthcare infrastructure are expected to bolster future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yersinia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yersinia Diagnostics Market Segments Analysis

Global Yersinia Diagnostics Market is segmented by Product, Diagnostic Test, Technology, End User and region. Based on Product, the market is segmented into Instruments and Kits and Reagents. Based on Diagnostic Test, the market is segmented into Stool Culture, Imaging Tests, Serological Tests, Colonoscopy, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy and Others. Based on Technology, the market is segmented into Immunoassay, DNA Probes, Polymerase Chain Reaction (PCR), Flow Cytometry, Chromatography and Others. Based on End User, the market is segmented into Hospitals, Public Health Laboratories, Commercial Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yersinia Diagnostics Market

One of the key market drivers for the global Yersinia diagnostics market is the increasing prevalence of Yersinia infections, particularly Yersinia pestis, which is responsible for plague, and Yersinia enterocolitica, a leading cause of gastroenteritis. The rise in infection rates, often linked to environmental factors, travel, and urbanization, has heightened the need for accurate and rapid diagnostic tests. Additionally, the growing awareness of zoonotic diseases and the importance of early detection in controlling outbreaks are propelling investments in research and development of sophisticated diagnostic tools, ultimately driving market growth and enhancing public health response mechanisms.

Restraints in the Global Yersinia Diagnostics Market

One significant market restraint for the global Yersinia diagnostics market is the limited awareness and understanding of Yersinia infections among healthcare professionals and the general public. This knowledge gap can lead to misdiagnosis or delayed diagnosis, subsequently hindering the demand for accurate diagnostic tools. Additionally, the relatively low prevalence of Yersinia infections in many regions may result in insufficient funding and research initiatives aimed at developing advanced diagnostic solutions, further impeding market growth. As a result, the lack of visibility and urgency surrounding Yersinia-related health issues poses a challenge for manufacturers and stakeholders in this specialized market segment.

Market Trends of the Global Yersinia Diagnostics Market

The Global Yersinia Diagnostics market is witnessing a significant shift towards molecular diagnostics, characterized by the growing adoption of innovative techniques such as polymerase chain reaction (PCR) assays and nucleic acid amplification tests (NAATs) for effective Yersinia detection. These advanced molecular methods are favored for their superior sensitivity and specificity compared to traditional culture-based techniques, alongside their ability to deliver rapid turnaround times. The capability to directly identify Yersinia DNA from clinical samples facilitates prompt and accurate diagnoses, prompting healthcare providers and laboratories to invest more heavily in molecular diagnostic platforms and assays, thereby catalyzing robust market growth in this segment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Yersinia Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Kits and Reagents

Global Yersinia Diagnostics Market Size by Diagnostic Test & CAGR (2026-2033)

Market Overview
Stool Culture
Imaging Tests
Serological Tests
Colonoscopy
ELISA
Radioimmunoassay
Tube Agglutination
CT Scan
Ultrasonography
Colonoscopy
Others

Global Yersinia Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunoassay
DNA Probes
Polymerase Chain Reaction (PCR)
Flow Cytometry
Chromatography
Others

Global Yersinia Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Public Health Laboratories
Commercial Laboratories
Others

Global Yersinia Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Diagnostic Test, Technology, End User)
- US
- Canada
Europe (Product, Diagnostic Test, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Diagnostic Test, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Diagnostic Test, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Diagnostic Test, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioAffinity Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gen-Probe Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments